Sodium Channel Inhibitor 1, identified by its CAS number 1198117-23-5, is a chemical compound that functions primarily as a pharmacological agent targeting sodium channels. These channels are integral membrane proteins that facilitate the flow of sodium ions across cell membranes, playing a crucial role in various physiological processes, including the generation and propagation of action potentials in neurons and muscle cells. The inhibition of sodium channels can lead to a reduction in excitability and is of particular interest in the treatment of conditions such as epilepsy, neuropathic pain, and cardiac arrhythmias. While specific physical and chemical properties such as solubility, melting point, and molecular weight may vary, compounds in this class typically exhibit a moderate to high degree of lipophilicity, allowing for effective cellular penetration. Additionally, the pharmacodynamics and pharmacokinetics of Sodium Channel Inhibitor 1 would be essential for understanding its therapeutic potential and safety profile. Further research and clinical studies would be necessary to fully elucidate its efficacy and mechanism of action in various biological systems.

SodiuM Channel inhibitor 1

1198117-23-5: Sodium Channel Inhibitor 1, identified by its CAS number 1198117-23-5, is a chemical compound that functions primarily as a pharmacological agent targeting sodium channels. These channels are integral membrane proteins that facilitate the flow of sodium ions across cell membranes, playing a crucial role in various physiological processes, including the generation and propagation of action potentials in neurons and muscle cells. The inhibition of sodium channels can lead to a reduction in excitability and is of particular interest in the treatment of conditions such as epilepsy, neuropathic pain, and cardiac arrhythmias. While specific physical and chemical properties such as solubility, melting point, and molecular weight may vary, compounds in this class typically exhibit a moderate to high degree of lipophilicity, allowing for effective cellular penetration. Additionally, the pharmacodynamics and pharmacokinetics of Sodium Channel Inhibitor 1 would be essential for understanding its therapeutic potential and safety profile. Further research and clinical studies would be necessary to fully elucidate its efficacy and mechanism of action in various biological systems.

Sodium Channel inhibitor1 is a novel and selective voltage-gated sodium channel for pain treatment.

CAS 1198117-23-5

SodiuM Channel inhibitor 1

Sodium Channel inhibitor 1

Ref: TM-T12948